These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18083)

  • 21. The in-vitro activity of azlocillin: a community hospital study of 1900 clinical isolates.
    Parry MF
    J Antimicrob Chemother; 1983 May; 11 Suppl B():15-20. PubMed ID: 6619025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
    Chin NX; Jules K; Neu HC
    Eur J Clin Microbiol; 1986 Feb; 5(1):23-8. PubMed ID: 2938945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillin.
    Bodey GP; Deerhake B
    Appl Microbiol; 1971 Jan; 21(1):61-5. PubMed ID: 4924999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semisynthetic penicillin 6-(D(--)-alpha-carboxy-3-thienylacetamido) penicillanic acid active against Pseudomonas in vitro.
    Neu HC; Winshell EB
    Appl Microbiol; 1971 Jan; 21(1):66-70. PubMed ID: 4993233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Mar; 13(3):358-67. PubMed ID: 122519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes.
    Basker MJ; Edmondson RA; Sutherland R
    Infection; 1979; 7(2):67-73. PubMed ID: 108220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Azlocillin--a new penicillin against Pseudomonas aeruginosa and other gram-negative bacteria].
    König HB; Metzger KG; Mürmann RP; Offe HA; Schacht P; Schröck W
    Infection; 1977; 5(3):170-82. PubMed ID: 410735
    [No Abstract]   [Full Text] [Related]  

  • 29. Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates.
    Fuchs PC; Gavan TL; Gerlach EH; Jones RN; Barry AL; Thornsberry C
    Am J Med Sci; 1977; 274(3):255-63. PubMed ID: 610415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)].
    Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A
    Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin.
    Phaneuf D; Neu HC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):625-30. PubMed ID: 118706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.
    Schassan HH; Koperski K; Scherf H
    Chemotherapy; 1978; 24(3):134-42. PubMed ID: 95925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study].
    Quentin C; Auzerie J; Bebear C; Acar JF; Kitzis MD; Avril JL; Moillo-Batt A; Shacoori Z; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1984 May; 32(5):301-6. PubMed ID: 6429608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
    Delgado DG; Brau CJ; Cobbs CG; Dismukes WE
    Antimicrob Agents Chemother; 1979 Dec; 16(6):864-8. PubMed ID: 533267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
    Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CI-867, a new semisynthetic penicillin: in vitro studies.
    Weaver SS; Bodey GP
    Antimicrob Agents Chemother; 1980 Dec; 18(6):939-43. PubMed ID: 7235679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB
    Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.